dr. tolaney discusses patient selection for platinum-based therapy in tnbc
Published 9 years ago • 91 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc
-
4:35
role of neoadjuvant platinum-based therapy for tnbc
-
1:32
dr tolaney on data with checkpoint inhibitor combinations in metastatic tnbc
-
1:19
dr. sara m. tolaney on neoadjuvant treatment considerations for tnbc
-
1:08
a study investigating pembrolizumab in combination with eribulin in tnbc
-
1:21
using platinum agents in different settings of tnbc
-
0:41
recent advances in targeted therapies for tnbc
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
3:06
dr. sara tolaney on adjuvant cisplatin and radiation for triple-negative breast cancer
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
1:07
hr status in determining the efficacy of platinum therapy in advanced tnbc
-
1:55
dr. tolaney on abemaciclib plus pembrolizumab for hr , her2- breast cancer
-
3:12
neoadjuvant versus adjuvant therapy in tnbc
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
1:39
dr tolaney on standard frontline treatment approaches in her2 breast cancer
-
1:07
phase ii results for pembrolizumab monotherapy in metastatic tnbc
-
1:10
comparing 3 types of targeted therapies for triple-negative breast cancer
-
1:09
sara m. tolaney on neoadjuvant treatment considerations for triple-negative breast cancer